Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, March 9, 2023
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
Geulah Livshits Maintained (TNYA) at Strong Buy with Decreased Target to $24 on, Mar 9th, 2023
Geulah Livshits of Chardan Capital, Maintained "Tenaya Therapeutics, Inc." (TNYA) at Strong Buy with Decreased Target from $28 to $24 on, Mar 9th, 2023.
Geulah has made no other calls on TNYA in the last 4 months.
There is 1 other peer that has a rating on TNYA. Out of the 1 peers that are also analyzing TNYA, 0 agree with Geulah's Rating of Hold.
This is the rating of the analyst that currently disagrees with Geulah
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $13 on, Tuesday, January 24th, 2023
